Yaz associated with a higher risk for blood clots
FDA has completed its review of recent observational (epidemiologic) studies regarding the risk of blood clots in women taking drospirenone-containing
Read MoreFaulty Pharmaceutical Drugs Resources
FDA has completed its review of recent observational (epidemiologic) studies regarding the risk of blood clots in women taking drospirenone-containing
Read More